Duloxetine sprinkles
US9839626B1 · kind B1 · utility
4Cited by
4References
16Claims
0Family size
Inventors
Key dates
| Filing date | Apr 13, 2017 |
| Grant date | Dec 12, 2017 |
| Priority date | — |
| Expiry date | Apr 13, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/5047
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates in part a to multiparticulate sprinkle dosage form comprising duloxetine or a pharmaceutically acceptable salt thereof, having higher acid resistance as compared to commercially available delayed release formulations. It further relates to various methods of administering the said multiparticulate sprinkle dosage forms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.